Clinical Trials on Mediastinal Neoplasms

Total 107286 results

University Hospitals, Leicester

Terminated

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

Esophageal Neoplasm | Gastric Neoplasm

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm

United States
Asan Medical Center
Olympus

Completed

Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy

Benign Neoplasm of Body of Pancreas | Benign Neoplasm of Tail of Pancreas
National Cancer Institute (NCI)

Recruiting

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Neoplasm Metastasis | Colorectal Neoplasm | Liver Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditions

United States
Peking Union Medical College Hospital
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

Hepatobiliary Neoplasm | Liver Neoplasm | Biliary Tract Neoplasms

China
National Cancer Institute (NCI)

Recruiting

Collection of Tissue Blocks or Slides From Patients With Cancer

Cancer | Tumor | Benign Neoplasms | Carcinogens | Neoplasm, Benign

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

Malignant Primary Pelvic Neoplasm

United States
Grupo Espanol de Tumores Neuroendocrinos

Completed

Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (DUNE)

Neuroendocrine Tumors | Neuroendocrine Neoplasm of Lung

Spain
MedSource Polska

Unknown

Nutritional Supplementation in Patients With no Signs of Malnutrition

Abdominal Neoplasm | Primary Neoplasm | Secondary Neoplasm

Poland
SynerGene Therapeutics, Inc.

Completed

Safety Study of Infusion of SGT-53 to Treat Solid Tumors

Neoplasm

United States
Bayer

Completed

Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies

Neoplasm

United States
Instituto do Cancer do Estado de São Paulo

Unknown

Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery

Neoplasm

Brazil
Piramal Enterprises Limited

Terminated

Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

India
National Cancer Institute (NCI)

Completed

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Neoplasm

United States
Icahn School of Medicine at Mount Sinai
NX Development Corp

Recruiting

The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

Neoplasm | Skull Base Neoplasm

United States
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI-JH04 PET/CT: Dosimetry and Biodistribution Studies

Malignant Neoplasm

China
Tyligand Bioscience (Shanghai) Limited

Recruiting

TSN084 Treating Patients With Advanced Malignant Tumors

Malignant Neoplasm

China
Guangzhou First People's Hospital

Recruiting

An Observational Clinical Study Plan on the Effects of Radiotherapy on the Immune System of Patients With Malignant Tumors.

Malignant Neoplasm

China
University Hospital Heidelberg

Recruiting

The Myeloid Neoplasms Biology and Outcome Project (MyBOP)

Myeloid Neoplasm

Germany
Wuhan Union Hospital, China

Recruiting

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Malignant Neoplasm

China
Imperial College London

Recruiting

iKnife REIMS Project (iKnife)

Neoplasms | Neoplasm Malignant

United Kingdom
University of Southern California
National Cancer Institute (NCI)

Terminated

18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

Malignant Neoplasm

United States
The Second Hospital of Lanzhou University

Completed

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Malignant Neoplasm

China
Sameek Roychowdhury

Active, not recruiting

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Malignant Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

Malignant Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family Caregivers

Malignant Neoplasm

United States
University Hospital, Essen

Completed

FAPI PET/CT Prospective Interobserver Agreement (AGREE-FAPI)

Malignant Neoplasm

Germany
Lawson Health Research Institute
London Health Sciences Centre

Completed

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

Malignant Neoplasm

Canada
Vanderbilt-Ingram Cancer Center

Terminated

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Malignant Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures

Malignant Neoplasm

United States
Sanofi

Completed

A Study of SAR428926 in Patients With Advanced Solid Tumors

Neoplasm Malignant

France, Denmark, Spain
Sanofi

Completed

Phase 1 Safety Testing of SAR405838

Neoplasm Malignant

United States, France, Netherlands
National Cancer Institute (NCI)

Completed

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

Malignant Neoplasm

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

Malignant Neoplasm

United States
Sanofi

Completed

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

Neoplasm Malignant

Japan
Sanofi

Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Neoplasm Malignant

United States
Ohio State University Comprehensive Cancer Center

Completed

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Malignant Neoplasm

United States
Institut Paoli-Calmettes

Completed

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm (METRO1)

Advanced Neoplasm

France
Jinsong Wu

Unknown

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

Central Nervous System Neoplasms
Bavarian Cancer Registry
Bavarian Association of Statutory Health Insurance Accredited Physicians

Not yet recruiting

Risk Factors for Neuroendocrine Neoplasms

Neuroendocrine Neoplasm of Lung | Neuroendocrine Neoplasm of Gastrointestinal Tract (Disorder)
M.D. Anderson Cancer Center
National Cancer Institute (NCI); University of Houston

Recruiting

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Brain Neoplasm | Metastatic Malignant Neoplasm in the Brain | Recurrent Brain Neoplasm

United States
Chuncheon Sacred Heart Hospital

Completed

Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy

Neoplasm

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)

Neoplasm
Sameek Roychowdhury

Active, not recruiting

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Cholangiocarcinoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
Dartmouth-Hitchcock Medical Center

Completed

Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study

Primary Malignant Neoplasm of Lung | Primary Malignant Neoplasm of Gastrointestinal Tract

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors

Head and Neck Neoplasm | Malignant Head and Neck Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Meningioma | Neuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Von Hippel-Lindau Syndrome | Metastatic Well Differentiated Neuroendocrine Neoplasm | Somatostatin Positive Neoplastic Cells Present

United States
Duke University
Makerere University; Uganda Cancer Institute

Not yet recruiting

KeyScope Study in Uganda

Abdominal Neoplasm

Uganda

Clinical Trials on Mediastinal Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations